Phase II study of gemcitabine (G) in combination with docetaxel (D) in advanced non-small-cell lung cancer (NSCLC) patients.: (Oncopaz and Hospitals Associated).

被引：0
|
作者：
García, C
Milla, A
Feliu, J
Lorenzo, A
Madroñal, C
Gili, F
Baena, JM
机构：
[1] H Gral Yague, Burgos, Spain
[2] Na Sa Pilar, Barcelona, Spain
[3] H La Paz, Madrid, Spain
[4] H Puerto Real, Cadiz, Spain
[5] Clin Corachan, Barcelona, Spain
[6] H Cruz Roja Hosp Llobregat, Barcelona, Spain
[7] H Puerta Mar, Cadiz, Spain
来源：
ANNALS OF ONCOLOGY | 2000年 / 11卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
516P
引用
收藏
页码：113 / 113
页数：1
相关论文
共 50 条
  • [21] Combination of docetaxel and gemcitabine effective in non-small-cell lung cancer
    不详
    ONCOLOGY-NEW YORK, 2001, 15 (02): : 186 - 186
  • [22] A phase II study of the docetaxel-ifosfamide-carboplatin combination in advanced non-small-cell lung cancer
    Kosmas, C
    Tsavaris, N
    Koutras, A
    Makatsoris, T
    Mylonakis, N
    Tzelepis, G
    Dimitrakopoulos, A
    Spyropoulos, K
    Polyzos, A
    Karabelis, A
    Kalofonos, HP
    ONCOLOGY, 2005, 69 (04) : 333 - 341
  • [23] Docetaxel and gemcitabine combination as first-line treatment in advanced or metastatic non-small-cell lung cancer: A multicenter phase II study
    Costa, A
    Almodovar, T
    Seada, J
    Barata, F
    Teixeira, E
    Queiroga, H
    Pires, S
    PROCEEDINGS OF THE 9TH CENTRAL EUROPEAN LUNG CANCER CONFERENCE, 2004, : 117 - 120
  • [24] Combination of docetaxel (DTX) and gemcitabine (G) in patients with inoperable or metastatic non-small cell lung cancer (NSCLC). A phase I study
    Rebattu, P
    Pujol, JL
    Ardiet, C
    Quentin, X
    Droz, JP
    Dumortier, A
    Khial, F
    Schuller, MP
    ANNALS OF ONCOLOGY, 1998, 9 : 95 - 95
  • [25] Triplet chemotherapy combination with gemcitabine, cisplatin and ifosfamide in patients with advanced non-small-cell lung cancer - Phase II study
    Mohedano, NM
    Rovira, PS
    Barriuso, AL
    Morales, MF
    Magan, BM
    Morago, AJ
    Quintela, IP
    Garcia, RD
    Flores, EF
    Moreno, MAM
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2003, 26 (04): : 363 - 365
  • [26] Sorafenib in combination with erlotinib or with gemcitabine in elderly patients with advanced non-small-cell lung cancer: a randomized phase II study
    Gridelli, C.
    Morgillo, F.
    Favaretto, A.
    de Marinis, F.
    Chella, A.
    Cerea, G.
    Mattioli, R.
    Tortora, G.
    Rossi, A.
    Fasano, M.
    Pasello, G.
    Ricciardi, S.
    Maione, P.
    Di Maio, M.
    Ciardiello, F.
    ANNALS OF ONCOLOGY, 2011, 22 (07) : 1528 - 1534
  • [27] Combination chemotherapy with carboplatin(CBDCA), docetaxel (DOC) and gemcitabine (GEM) in advanced non-small cell lung cancer (NSCLC). A phase II study
    Pectasides, D
    Aspropotamitis, A
    Halikia, A
    Visvikis, A
    Antoniou, F
    Kalantaridou, A
    Batzios, S
    Karvounis, N
    Athanassiou, A
    EUROPEAN JOURNAL OF CANCER, 1999, 35 : S263 - S263
  • [28] Gemcitabine (GEM) Cisplatin (CDDP) Vinorelbine (VNR) combination in advanced non-small-cell lung cancer (NSCLC). A phase II randomized study
    Comella, P
    Panza, N
    Frasci, G
    Pacillo, C
    Nicolella, GP
    Natale, M
    DeCataldis, G
    Manzione, L
    Bilancia, D
    Cioffi, R
    Micillo, E
    Maiorino, L
    Lorusso, V
    Ianniello, GP
    DellaVittoria, M
    Piantedosi, F
    Perchard, J
    Comella, G
    EUROPEAN JOURNAL OF CANCER, 1997, 33 : 1037 - 1037
  • [29] Preliminary results of a phase II trial of Docetaxel (D) and Gemcitabine (G) in advanced Non-Small Cell Lung Cancer (NSCLC) in elderly and/or unfit patients (PTS)
    Buffoni, Lucio
    Grillo, Raffaella
    Barone, Carla
    Dongiovanni, Diego
    Gaspari, Fabio
    Giacobino, Alice
    Consito, Lorena
    Ciuffreda, Libero
    Schena, Marina
    JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (09) : S668 - S668
  • [30] First line chemotherapy with sequential administration of gemcitabine followed by docetaxel in elderly advanced non-small-cell lung cancer (NSCLC) patients: A multicenter phase II study
    Lo Dico, M.
    Vasile, E.
    Tibaldi, C.
    Antonuzzo, A.
    Di Marsico, R.
    Tartarelli, G.
    Fabbri, A.
    Mazzoni, E.
    Andreuccetti, M.
    D'Alessandro, M.
    Nacci, A.
    Falcone, A.
    ANNALS OF ONCOLOGY, 2007, 18 : 35 - 35
12345